Nuvation BiovsThermo Fisher Scientific

NUVB and TMO stock compared: price, dividend, valuation and results, from SEC filings.

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

Nuvation Bio (NUVB) has a market value of $1.3B and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, NUVB moved -19.1% and TMO +19.5%. Dividend yield: NUVB none, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    NUVB$1.3B

    TMO$260B

    TMO is 193 times NUVB

  • Revenue, 12 months

    NUVB$202M

    TMO$47.4B

    TMO is 235 times NUVB

  • Net income, 12 months

    NUVB-$136M

    TMO$7.1B

  • Operating margin

    NUVB-61.2%

    TMO17.9%

    79.1 points apart

  • ROIC

    NUVB-22.9%

    TMO8.2%

    31.1 points apart

  • P/E

    NUVB–

    TMO36.8

  • Dividend yield

    NUVB0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    NUVB-57.6%

    TMO+11.8%

    69.4 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

NUVB-57.6%

TMO+11.8%

5010020222023202420252026
Returns by period
PeriodNUVBWith dividendsTMOWith dividends
1 year since November 12, 2025-19.1%Price -19.1%+19.5%Price +19.1%
3 years since November 13, 2023+211.7%+46.1% a yearPrice +211.7%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021-57.6%-15.8% a yearPrice -57.6%+11.8%+2.3% a yearPrice +10.2%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

NUVBNuvation BioTMOThermo Fisher Scientific

Valuation

NUVBTMO
Valuation
Price$3.99$700.22
Market value$1.3B$260B
Enterprise value (EV)$970M$295B
P/E–36.8
P/E, 5-year median–32.7
P/B5.94.8
EV/EBIT–34.9
Free cash flow yield–2.9%

Results and growth

NUVBTMO
Results and growth
Revenue, 12 months$202M$47.4B
Net income, 12 months-$136M$7.1B
Free cash flow, 12 months-$106M$7.6B
Earnings per share, 12 months-$0.40$18.96
Revenue growth, year on year699.0%3.9%
Revenue growth a year, past–+6.7%over 5 years
EPS growth a year, past–+2.1%over 5 years

Margins and returns on capital

NUVBTMO
Margins and returns on capital
Gross margin7.2%–
Operating margin-61.2%17.9%
Net margin-67.4%14.9%
ROIC-22.9%8.2%
ROE-47.4%13.4%

Balance sheet

NUVBTMO
Balance sheet
Cash$663M$6.1B
Total debt$300M$41.4B
Net debt / EBITDA–3.7
Interest cover-5.9×5.5×

Dividends and buybacks

NUVBTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: NUVB or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Nuvation Bio or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 193.0 times Nuvation Bio ($1.3B), at today's prices.

How did NUVB and TMO stock do over the last 5 years?

Since November 12, 2021, NUVB's price moved -57.6% and TMO's +10.2%. With dividends: NUVB -57.6% (-15.8% a year), TMO +11.8% (+2.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, NUVB or TMO?

The dividend yield at today's price is none for Nuvation Bio and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Nuvation Bio or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -67.4% for Nuvation Bio and 14.9% for Thermo Fisher Scientific, and the operating margin -61.2% and 17.9%. Revenue was $202M and $47.4B.

Which is the better investment, Nuvation Bio or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.